LUCD — Lucid Diagnostics Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1799011 ·
Last close
$0.40
Market Cap
$77.69M
52W High
$1.63
52W Low
$0.30
ADV30
9,396,622
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 1,203,000 | -201,000 | -12,276,000 | -6,677,000 | 27,857,000 | 17,993,000 | 21,925,000 |
| Jun 2026 | 1,474,000 | 29,000 | -12,801,000 | -11,687,000 | 38,946,000 | 33,404,000 | 28,019,000 |
| Mar 2026 | 1,256,000 | -369,000 | -12,114,000 | -13,909,000 | 34,080,000 | 27,876,000 | 30,080,000 |
| Dec 2025 | 1,504,000 | -356,000 | -14,011,000 | -16,266,000 | 40,445,000 | 34,705,000 | 29,509,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-51,526,000
Investing CF
$-304,000
Financing CF
$22,491,000
CapEx
$-304,000
Dividends Paid
—
Buybacks
$-21,000
EPS Diluted TTM
$-0.38
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-319,355,000
Inventory
$520,000
Receivables
$843,000
ST Investments
—
EBIT TTM
$-48,522,000
Pretax Income TTM
$-48,539,000
Interest Exp TTM
$17,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,436,000
EBITDA
$-50,321,000
Free Cash Flow
$-30,776,250
Enterprise Value
$86,901,168
Total Cash
$19,029,000
Total Debt
$18,487,000
Shares Out
194,707,560
Trailing EPS
$-0.36
Book Value
$0.03
ROE
-305.6%
ROA
-79.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,706,000 | -49,640,000 | -58,010,000 | 40,445,000 | 29,509,000 | 10,936,000 | -46,485,000 |
| Dec 2024 | 4,346,000 | -46,052,000 | -45,529,000 | 30,715,000 | 25,324,000 | 5,391,000 | -44,140,000 |
| Dec 2023 | 2,428,000 | -48,482,000 | -52,666,000 | 27,270,000 | 29,581,000 | -2,311,000 | -32,817,000 |
| Dec 2022 | 377,000 | -56,251,000 | -56,171,000 | 32,509,000 | 9,462,000 | 23,047,000 | -29,685,000 |
TTM Snapshot
Revenues TTM
$5,445,000
NetIncome TTM
$-52,259,000
OpCashFlow TTM
—
Assets (Latest)
$38,946,000
Forward EPS
$-0.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RTGN | RetinalGenix Technologies Inc. | $75.19M | $3.99 | — |
| LAKE | LAKELAND INDUSTRIES INC | $82.33M | $8.29 | — |
| EBRCZ | EBR Systems, Inc. | $70.01M | $0.08 | — |
| STXS | Stereotaxis, Inc. | $88.39M | $0.88 | — |
| APT | ALPHA PRO TECH LTD | $68.25M | $6.65 | — |
News headlines (Yahoo Finance, 1h cache)
PAVmed Provides Business Update and Reports Preliminary Third Quarter 2026 Financial Results
2026-11-13 13:00 · Yahoo
Lucid Diagnostics Inc (LUCD) Q3 2026 Earnings Call Highlights: Medicare Reimbursement ...
2026-11-12 23:06 · Yahoo
What Lucid Diagnostics (LUCD) Said on Its Q3 Earnings Call
2026-11-12 20:14 · Yahoo
Lucid Diagnostics Inc. Q3 2026 Earnings Call Summary
2026-11-12 17:54 · Yahoo
Lucid Diagnostics (LUCD) Q3 2026 Earnings Call Transcript
2026-11-12 15:59 · Yahoo
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates
2026-11-12 13:15 · Yahoo
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results
2026-11-12 13:00 · Yahoo
Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year
2026-11-05 13:25 · Yahoo
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
2026-11-04 13:55 · Yahoo
Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study
2026-11-03 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.